Evidence map›Paper›PMID 14500811›Full record

ArticleNucleic acids research2003

Using pyrene-labeled HIV-1 TAR to measure RNA-small molecule binding.

Kenneth F Blount, Yitzhak Tor

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Nucleic acids research, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. A Riboswitch-Driven Era of New Antibacterials.Antibiotics (Basel, Switzerland) · 2022
    Review
  3. Target-Directed Approaches for Screening Small Molecules against RNA Targets.SLAS discovery : advancing life sciences R & D · 2020
    Review
  4. Article
  5. Small Molecule-Based Pattern Recognition To Classify RNA Structure.Journal of the American Chemical Society · 2017
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kenneth F BlountDepartment of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA.
Yitzhak Tor
University of California, San Diego · US

Funding

NOVEL APPROACHES TO THE DISCOVERY OF ANTI-HIV AGENTSR01AI047673 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TOR, YITZHAK · 2000 to 2007
$2.3M
Enhancing RNA binding selectivity of guanidinoglycosidesF32GM065652 · NIGMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI BLOUNT, KENNETH F · 2003 to 2005
$96k
NIAID NIH HHS AI47673NIAID NIH HHS R01 AI047673NIGMS NIH HHS 1 F32 GM065652-01A1NIGMS NIH HHS F32 GM065652
6 · The paper itself

Abstract

To quantitatively understand the binding affinity and target selectivity of small-molecule RNA interactions, it is useful to have a rapid, highly reproducible binding assay that can be readily generalized to different RNA targets. To that end, an assay has been developed and validated for measuring the binding of low-molecular weight ligands to RNA by monitoring the fluorescence of a covalently incorporated fluorophore. As a test system, the fluorescence of a pyrene-derivatized HIV-1 TAR (transactivating response element) RNA was measured upon titration with aminoglycoside antibiotics. The binding isotherms thus obtained fit well with a model for a 1:1 interaction and yield an accurate measure of the equilibrium dissociation constant. Among a series of natural aminoglycosides, the binding affinity correlates with the number of amines, supporting an electrostatic compensation model for binding. Furthermore, the ionic strength dependence confirms that much of the binding energy is electrostatic. Finally, by measuring the binding affinity in the presence of nucleic acid competitors, we confirm that although aminoglycosides show high RNA to DNA selectivity, their selectivity among different RNA targets is sub- optimal. We conclude that this newly developed assay can be generalized to measure the binding affinities and selectivities of a variety of small molecules to a specific RNA target.

Indexed as

HIV Long Terminal RepeatAminoglycosidesBase SequenceBinding, CompetitiveBinding SitesEndoribonucleasesFluorescent DyesFramycetinHIV-1Models, MolecularNeomycinNucleic Acid ConformationOsmolar ConcentrationPyrenesRNASpectrometry, FluorescenceAminoglycosidesEndoribonucleasesFluorescent DyesFramycetinNeomycinPyrenesribonuclease V(1)RNA

Identifiers

PMID14500811
PMCPMC206455
OpenAlexW2170554218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.